微芯生物：10月30日召开董事会会议

Group 1 - The company Microchip Biotech (SH 688321) announced on October 31 that its 17th meeting of the third board of directors for 2025 was held on October 30, 2025, combining in-person and communication methods [1] - The company reported that for the year 2024, its revenue composition is 97.96% from the pharmaceutical manufacturing industry and 2.04% from other businesses [1] - As of the report, Microchip Biotech has a market capitalization of 12.6 billion yuan [1]